CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
Alcohol may have immediate effect on atrial fibrillation risk, events
17 May 2021Study shows early preterm births can be decreased with DHA supplementation
17 May 2021CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
The journal Oncotarget has published “The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy” which reports that calcium-binding tyrosine phosphorylation-regulated protein is expressed in the human germ line but not in adult human tissues, thus, it is considered a cancer testis protein.
